It was an unanticipated event that led to what researchers are calling one of the greatest advancements to date in our understanding of early-stage embryos, called a blastocyst: the tiny ball of cells that has the potential to become an embryo and, eventually, a human.
The research has just beenpublishedin Nature.
Two years ago, an international team of scientists led by Monash Universitys Professor Jose Polo werestudying how induced pluripotent stem cells (iPS cells), a type of cell similar to an embryonic stem cells but derived from skin or blood cells, can be reprogrammed into any other human cell.
But Polos team noticed something other groups had missed: when they reprogrammed the cells, not all did as they were told.
Some about two per cent seemed to activate a library of unexpected genes. So using single-cell transcriptomics, a technique that can look at the gene expression of individual cells, Polo discovered the cells were activating genes youd expect to see in the early days of embryogenesis the period after a sperm has fertilised an egg.
In a flat Petri dish, the cells did little more than flash these unexpected genes. But cells are not isolated entities in the body; they work together to form complex structures, sending each other signals as they go. Polos team wondered what might happen if they were given the chance to talk.
So they took these cells that had been growing on a flat-surfaced Petri dish andplaced them on an AggreWell microwell. These structures, often used for stem-cell research, look like an inverted pyramid, with the cells, in solution, sitting clustered at the bottom of the well. Then the team left them to interact.
What we realised was that six days later, the cells had become balls of organised cells, so we asked ourselves: what are these balls? Polo says.
To get an answer, the team neededmolecular data they needed to know which genes and proteins were active in which cells. They solved this with microscopy, looking at biomarkers. They also used some sophisticated genomic approaches (called single-cell transcriptomics) to investigate.
They also needed to consider cellular architecture: they needed to see and analyse the structural look, shape and location of the cells. They also did this with microscopy. Last, to understand how the cells behaved, they conducted a battery of complex analyses.
With results in, the team dubbed the cell balls iBlastoids. And while they may resemble an IVF early-stage embryo, they are by no means identical. One of the three cell types in the blastocyst known as primitive endoderm (the layer that will become the yolk sac) was not well defined in the iBlastoids.
This discovery is still really important; even if they are a model and not the exact thing, they will provide valuable data when it comes to finding out more about why miscarriage occurs, and perhaps point to causes of infertility, Polo says.
At the moment, everything we know about the earliest stages of human development is from studying IVFembryos donated to science. Polo says this discovery will allow researchers to not only learn the role of any gene or mutation happening in the implantation period, but also better understand how toxins and drugs affect the first stage of human development.
While the International Society for Stem Cell Research (ISSCR) expects to release an update to its guidelines for stem cell research and clinical translation later this year,existing guidance published in 2016 recommends that this is an area of research only permissible following appropriate review and the need for a compelling scientific rationale. (See Ethics and embryos for more about the ethical considerations of this work.)
The Polo teams work draws on the discovery of Nobel Prize winner Shinya Yamanaka, who in2007 showedthat it is possible to transform ordinary adult skin cells into cells that, like embryonic stem cells (which can develop into each of the more than 200 cell types of the adult body as long as they are specified to do so), are capable of developing into any cell in the human body.
In 2007 (2006 in mice), Yamanaka discovered that by adding just four factors into adult skin cells from humans, he could induce the cells to become like embryonic stem cells. He called them induced pluripotent stem cells, or iPS cells.
Since this discovery, iPS cells have become an important tool for modelling how various organs in the body form, for investigating human disease and for screening drugs. But until the Polo teams discovery and the discovery made by a second group of researchers, alsopublishedinNatureon Thursday, but using a different method it was not clear whether iPS cells were able to model human blastocyst development.
Previous studies in mice had built blastoids using stem cells, and other researchers had used stem cells to model other aspects of post-implantation. But this is the first time that an integrated model of the earliest stage has been generated in human cells.
Professor Megan Munsie, deputy director of the University of Melbournes Centre for Stem Cell Systems, says while the findings are building on previous, similar, research, theyre nonetheless an invaluable step towards potentially understanding the role of infertility, miscarriages and even the effects of other drugs on early human development.
Its amazing that these cells can self-assemble and replicate something that looks like this early stage of human development, she says.
And while its a valuable first step, replicating the results on a bigger and more consistent scale is another thing altogether, Munsie says.
Yes, weve done this, but the question now is: how reliable is this as a model? A lot more needs to be done around understanding the limitations of this technology.
Both papers talk about the inefficiency of their approach: while you can stick these cells together only some of them will form the blastoids, and we dont yet know why it happened or even how it happened. Once we figure that out, we can look for other applications.
Dr Peter Rugg-Gunn, group leader at the Babraham Institute in Cambridge, UK, says that while both studies provide an exciting advance by describing conditions to engineer human blastocyst-like structures in the laboratory the next steps of the research will be to optimise the conditions to improve the efficiency of forming the blastocyst-like structures.
Currently, only 1 in 10 attempts to create these structures result in success, and the pace at which they form is inconsistent.
To capitalise on the discovery, the process will need to be more controlled and less variable, Rugg-Gunn says, adding that its also important to establish in future research which aspects of human early development the blastocyst-like structures are able to recapitulate.
If the structures can shed light on how the cell types in a blastocyst communicate with each other and also help identify the key factors that are required for lineage formation and development, then this will be a very informative cell model.
Human skin cells are being reprogrammed by a cocktail of reprogramming factors (RF). During reprogramming, these are then placed into V-shaped microwells, where they gradually develop into a blastocyst-like 3D cellular structure called an iBlastoid. Credit: Monash BDI.
Read the original:
Science and blastocysts - Cosmos
- Panasonic and Shinobi Therapeutics Partner to Develop Efficient and Cost-Effective iPS Cell Therapy Manufacturing ... - PR Newswire - April 24th, 2024
- SCG CELL THERAPY AND A*STAR LAUNCH JOINT LABS WITH COLLABORATION NEARING S$30 MILLION TO ... - PR Newswire - April 20th, 2024
- Detection of biomagnetic signals from induced pluripotent stem cell-derived cardiomyocytes using deep learning with ... - Nature.com - April 1st, 2024
- Researchers discover new microRNA-regulated pathway to boost iPS cell-derived platelet production - Phys.org - March 30th, 2024
- Standardized production of hPSC-derived cardiomyocyte aggregates in stirred spinner flasks - Nature.com - March 28th, 2024
- Synthetic Circuits Reveal the Key to Rewinding the Cellular Clock - The Scientist - March 13th, 2024
- synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy - Nature.com - March 3rd, 2024
- Breaking through new research barriers with iPSC technology - News-Medical.Net - February 15th, 2024
- Abu Dhabi Stem Cells Centre partners with Rege Nephro and Kyoto University's Center for iPS Cell Research and ... - Abu Dhabi Media Office - January 12th, 2024
- Abu Dhabi Stem Cells Center partners with Japan-based Kyoto University and Rege Nephro - ZAWYA - January 12th, 2024
- Efficient and reproducible generation of human induced pluripotent stem cell-derived expandable liver organoids for ... - Nature.com - December 23rd, 2023
- Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming - Nature.com - December 15th, 2023
- Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform - PR Newswire - December 13th, 2023
- CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes ... - Nature.com - December 7th, 2023
- World Hindu Congress 2023: Know all about the sessions and speakers - Organiser - November 23rd, 2023
- VCCT Inc., Leading the Field of Retinal Regeneration through iPS ... - Business Wire - November 21st, 2023
- Efficient protocol for the differentiation of kidney podocytes from ... - Nature.com - November 17th, 2023
- Vitamin B12 is a limiting factor for induced cellular plasticity and ... - Nature.com - November 17th, 2023
- Study reveals the critical role of microglia in human brain development - Medical Xpress - November 15th, 2023
- VCCT Inc., Leading the Field of Retinal Regeneration through iPS Cells, Raises 600 million Japanese yen (approximately $4 million USD) through... - November 15th, 2023
- Who are the leading innovators in iPSCs for the pharmaceutical ... - Pharmaceutical Technology - November 7th, 2023
- Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous... - November 5th, 2023
- Systematic differences in discovery of genetic effects on gene ... - Nature.com - October 21st, 2023
- Pairwise biosynthesis of ion channels stabilizes excitability and ... - pnas.org - October 11th, 2023
- Scientists find multitude of genes associated with autism - The Statesman - October 9th, 2023
- Stem Cell Banking Market is Expected to Reach USD 16,474.30 ... - Digital Journal - October 7th, 2023
- Probing the individuality of cells and molecules - Open Access Government - October 5th, 2023
- Thymmune Therapeutics Receives $37M in Funding from the ... - Manchestertimes - October 3rd, 2023
- Thymmune Therapeutics Receives $37M in Funding from the ... - Business Wire - September 29th, 2023
- Less Funding to More Researchers Gets Nobel-level Results, Study ... - The Japan News - September 27th, 2023
- Brentuximab Vedotin Plus AVD Gets Positive CHMP Opinion for ... - OncLive - September 20th, 2023
- DKMS BMST Foundation India and Kokilaben Hospital unite to spread awareness about the Importance of Stem Cell Donation on World Marrow Donor Day - APN... - September 18th, 2023
- Vitamin B6 is governed by the local compartmentalization of ... - Science - September 14th, 2023
- Dolly the sheep creator Ian Wilmut dies aged 79 - BBC - September 14th, 2023
- Scientist who created Dolly the sheep dies aged 79: Professor Sir Ian Wilmut passes away five years after reve - Daily Mail - September 11th, 2023
- The global kits market is expected to grow at a CAGR of 7.4% from ... - Digital Journal - September 8th, 2023
- Eterna Therapeutics Announces Initiation of Development Activities ... - PipelineReview.com - September 8th, 2023
- Tokyo: 100 Years of Urban Regeneration / Tokyo's Nihonbashi Area ... - The Japan News - August 31st, 2023
- Transcriptome-based prediction of drugs, inhibiting ... - Nature.com - August 30th, 2023
- From the birds and the bees to IVG - The Gauntlet - August 26th, 2023
- Breakthrough creates stem cells without any memories - Freethink - August 26th, 2023
- Aging impairs the neurovascular interface in the heart - Science - August 26th, 2023
- For This Venture Capitalist, Research on Aging Is Personal; 'Bob ... - The Wall Street Journal - August 22nd, 2023
- Unleashing Potential: Illuminating the Future of Healthcare through Revolutionary Induced Pluripotent Stem Cel - openPR - August 18th, 2023
- A 'memory wipe' for stem cells may be the key to better therapies - The Conversation - August 16th, 2023
- Erasing epigenetic 'memory' to improve the quality of stem cells - FierceBiotech - August 16th, 2023
- HebeCell and Logomix Announce Collaboration for the ... - Business Wire - August 16th, 2023
- HebeCell and Logomix Announce Collaboration for the ... - Valdosta Daily Times - August 11th, 2023
- Advancing Clinical Trials with iPSC-Derived Liver Organoids - Microbioz India - August 11th, 2023
- Activation of cAMP (EPAC2) signaling pathway promotes hepatocyte ... - Nature.com - August 1st, 2023
- IPS HEART Announces Peer-Reviewed Publication in Cells of Aging Damage Reversal Showing GIVI-MPC Stem Cell Therapys Ability to Create New Skeletal... - July 30th, 2023
- Femtech in Japan: An Industry on the Rise - Femtech Insider - July 28th, 2023
- Association between enhanced carbonyl stress and decreased ... - Nature.com - July 28th, 2023
- Defects in early synaptic formation and neuronal function in Prader ... - Nature.com - July 27th, 2023
- IPS HEART Announces Peer-Reviewed Publication in Cells of ... - Business Wire - July 25th, 2023
- Cure to Autism and Alzheimer's May Be in Space, Says 1st Brazilian Scientist who Will Be on The ISS - Folha de S.Paulo - July 25th, 2023
- Futurama's Resurrection Ruins The Perfect Ending (& Shows Must ... - Looper - July 25th, 2023
- University Of Massachusetts Amherst's Team Bags Honour Of 2023 Armstrong Fund For Science Award - India Education Diary - July 20th, 2023
- Scientists working on IVG, a new reproductive method that can make human babies in labs - IndiaTimes - July 19th, 2023
- Co-transplantation of autologous Treg cells in a cell therapy for ... - Nature.com - July 13th, 2023
- Magic Valley and Biocellion Join Forces to Improve Bioreactor Tech ... - vegconomist - the vegan business magazine - July 13th, 2023
- IPS HEART Receives U.S. FDA Rare Pediatric Drug Designation for ... - Tullahoma News and Guardian - July 10th, 2023
- Hitachi : forms strategic research collaboration with Mass General Brigham in the field of regenerative medicine and GCT - Marketscreener.com - July 6th, 2023
- Cell therapy limitations with iPS-based multi-cell therapeutics - Drug Target Review - July 6th, 2023
- Remembering Dolly- The Clone Sheep On Her Birth Anniversary - Free Press Journal - July 4th, 2023
- Labs and Translational Research - UMass Medical School - June 28th, 2023
- Cellusion raises 2.83B series C round to progress iPS cell-derived ... - BioWorld Online - June 14th, 2023
- Japan-based Fujifilm introduces first-of-its-kind human iPSC-derived ... - BSA bureau - June 6th, 2023
- ALS: Parkinson's drug ropinirole may be an effective treatment - Medical News Today - June 4th, 2023
- Scientists predict lab-grown babies in five years - Kidspot - June 4th, 2023
- Lab-grown babies could become a reality within five years - Earth.com - May 26th, 2023
- Leading healthcare experts from MENA and beyond to explore the future of precision medicine in the region at PMES 23 this month - ZAWYA - May 24th, 2023
- Long-Awaited Ax-2 Mission Launches, Heads to Space Station - AmericaSpace - May 22nd, 2023
- Eterna Therapeutics and Factor Bioscience Announce New Data on ... - GlobeNewswire - May 17th, 2023
- Research Assistant job with UNITED ARAB EMIRATES ... - Times Higher Education - May 10th, 2023
- Regulation of synaptic connectivity in schizophrenia spectrum by ... - Nature.com - April 29th, 2023
- Researchers Discover Key Role of Glucose in Brain Activity - Laboratory Equipment - April 25th, 2023
- Structure of Huntington's Protein Revealed - Technology Networks - April 21st, 2023
- Study of brain immune cell infection may explain long COVID ... - NHK WORLD - April 19th, 2023
- The Mechanism That Regulates Activity of Memory Gene - Neuroscience News - April 19th, 2023
Recent Comments